Last updated on December 2019

Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa)

Brief description of study

The primary objective of the study is to determine the safety of single doses of DTX401, including the incidence of dose-limiting toxicities (DLTs) at each dose level.

Clinical Study Identifier: NCT03517085

Find a site near you

Start Over

UCONN Health

Farmington, CT United States
  Connect »